Metraipolis › archive › dc_0bcd5570993d

Prevalence of gastrointestinal side effects in hepatocellular carcinoma patients receiving sorafenib: a meta-analysis of 136 studies and 14,416 patients — Europe PMC PMID:42153092

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42153092
DOI
10.1177/17588359261442686
License (as archived)
solo-consultazione
Archived
2026-10-08T10:19:37.281Z
SHA-256 of the archived text
4860c5cacbc0b57d299c1127de83f0a6e1cc7d6ead06dde975310e3e0c6d50b6
Stable URL of this page
https://metraipolis.com/documento/dc_0bcd5570993d

How to cite

Prevalence of gastrointestinal side effects in hepatocellular carcinoma patients receiving sorafenib: a meta-analysis of 136 studies and 14,416 patients — Europe PMC PMID:42153092 — Europe PMC (en), https://europepmc.org/article/MED/42153092 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0bcd5570993d (Metraipolis archive dc_0bcd5570993d, sha256 4860c5cacbc0b57d299c1127de83f0a6e1cc7d6ead06dde975310e3e0c6d50b6)
BibTeX
@misc{dc0bcd5570993d,
  title = {Prevalence of gastrointestinal side effects in hepatocellular carcinoma patients receiving sorafenib: a meta-analysis of 136 studies and 14,416 patients — Europe PMC PMID:42153092},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42153092},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0bcd5570993d; sha256 4860c5cacbc0b57d299c1127de83f0a6e1cc7d6ead06dde975310e3e0c6d50b6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42153092. Agents can read the archived copy with the MCP tool read_document.